QUIMEDI
ActiveSummary
QUIMEDI has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €57,142 and a net result of €29,086. Equity is growing by about 17% per year across the filed financial years. The computed 12-month bankruptcy probability is 1.3% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
05-10
NBB filing
Annual accounts filed
financial year 2025 · micro format · 66 days late
2025
16-09
NBB filing
Annual accounts filed
financial year 2024 · micro format · 47 days late
2024
31-12
Financial
Weakest financial yearnet €19,619 ▼43.2%
Net result drops to €19,619, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity more than triplescurrent ratio 1.03
Current ratio from 0.27 to 1.03; short-term debt falls from €46,727 to €44,040.
30-09
NBB filing
Annual accounts filed
financial year 2023 · micro format · 61 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.